Shelile Pharma's capacities for DL-Aspartic acid and others become operational

Summary: The Phase II of Shelile Pharma's "amino acids construction project" passed EP acceptance check, introducing 2,400 t/a of production capacities in total for amino acids and derivatives.On 11 June, the report of post-completion environmental p...

Amino Acids China E-News 202406

www.cnchemicals.com